fbpx

10:50 – 11:05

Patient-reported outcomes (PROs) from the Ph 3 IMpassion031 trial of neoadjuvant (NA) atezolizumab + chemo in early triple-negative breast cancer (eTNBC)

GS3-02

Social Share

× How can I help you?